CLINICAL_TRIALS
trial_result
· 2024-12-17
Clinical Trial Update: Study of Pembrolizumab and Olaparib in Bile Duct Cancer [Phase 2]
Summary
Phase 2 trial of pembrolizumab plus olaparib in cholangiocarcinoma has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Georgetown University | Conditions: Cholangiocarcinoma | Phase 2 | Status: COMPLETED | Results posted: 2024-12-17